{"database": "openregs", "table": "documents", "rows": [["FDA-2011-N-0830-0024", "FDA", "FDA-2011-N-0830", "Reference 2 -1 - Final Regulatory Impact Analysis, Final Regulatory Flexibility Analysis, and Unfunded Mandates Reform Act Analysis for ANDAs and 505(b)(2) Apps; Final Rule re Abbreviated New Drug Applications and 505(b)(2) Applications", "Supporting & Related Material", "Background Material", "2016-10-06T04:00:00Z", 2016, 10, null, null, "2016-10-06T15:46:41Z", null, 0, 0, "09000064822a0aac"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2011-N-0830-0024"], "units": {}, "query_ms": 0.15744499978609383, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}